Guidelines and literature
Oncology and PET/CT Gallery
- 2017
18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study.
Na, S. J., Oh, J. K., Hyun, S. H., Lee, J. W., Hong, I. K., Song, B. I., . . . Yun, M. (2017). (18)F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study. J Nucl Med, 58(5), 730-736. doi:10.2967/jnumed.116.182022
- 2017
18F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?
Barrington, S. F., & Johnson, P. W. M. (2017). (18)F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality? J Nucl Med, 58(10), 1539-1544. doi:10.2967/jnumed.116.181347
- 2017
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 (2017)
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Ceci, F., Cho, S., . . . Herrmann, K. (2017). 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 44(6), 1014-1024. Retrieved from https://doi.org/10.1007/s00259-017-3670-z. doi:10.1007/s00259-017-3670-z
- 2017
A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies.
Liu, B., Gao, S., & Li, S. (2017). A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies. Gynecol Obstet Invest, 82(3), 209-222. doi:10.1159/000456006
- 2017
Appropriate Use Criteria for FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease (2017)
Jadvar, H., Colletti, P. M., Delgado-Bolton, R., Esposito, G., Krause, B. J., Iagaru, A. H., . . . Griffeth, L. (2017). Appropriate Use Criteria for (18)F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med, 58(12), 2026-2037. doi:10.2967/jnumed.117.197988
- 2017
Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith, A. F., Hall, P. S., Hulme, C. T., Dunn, J. A., McConkey, C. C., Rahman, J. K., . . . Mehanna, H. (2017). Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer. Eur J Cancer, 85, 6-14. doi:10.1016/j.ejca.2017.07.054
- 2017
Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis.
Ma, H., Shen, G., Liu, B., Yang, Y., Ren, P., & Kuang, A. (2017). Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis. Nucl Med Commun, 38(2), 156-163. doi:10.1097/mnm.0000000000000618
- 2017
Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis.
Nie, J., Zhang, J., Gao, J., Guo, L., Zhou, H., Hu, Y., . . . Ma, X. (2017). Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis. PLOS ONE, 12(5), e0175401. doi:10.1371/journal.pone.0175401
- 2017
Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
Ruilong, Z., Daohai, X., Li, G., Xiaohong, W., Chunjie, W., & Lei, T. (2017). Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis. Nucl Med Commun, 38(1), 67-75. doi:10.1097/mnm.0000000000000605
- 2017
Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou, Y., Tong, J., Leng, H., Jiang, J., Pan, M., & Chen, Z. (2017). Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis. Oncotarget, 8(25), 41518-41528. doi:10.18632/oncotarget.17456
- 2017
Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Chen, L., Yang, Q., Bao, J., Liu, D., Huang, X., & Wang, J. (2017). Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. Sci Rep, 7(1), 8479. doi:10.1038/s41598-017-08852-8
- 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging (2017)
Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., . . . Vullierme, M. P. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology, 105(3), 212-244. doi:10.1159/000471879
- 2017
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Cheson, B. D., & Kostakoglu, L. (2017). FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma. Oncology (Williston Park), 31(1), 45-49.
- 2017
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
Kostakoglu, L., Goy, A., Martinelli, G., Caballero, D., Crump, M., Gaidano, G., . . . Sehn, L. (2017). FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study. Leuk Lymphoma, 58(2), 372-381. doi:10.1080/10428194.2016.1196815
- 2017
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert, T., Helsen, N., Carp, L., Hakim, S., Martens, M. J., Hutsebaut, I., . . . Stroobants, S. (2017). Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study. J Clin Oncol, 35(30), 3458-3464. doi:10.1200/jco.2017.73.5845
- 2017
Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI.
Kunz, W. G., Jungblut, L. M., Kazmierczak, P. M., Vettermann, F. J., Bollenbacher, A., Tonn, J. C., . . . Cyran, C. C. (2017). Improved Detection of Transosseous Meningiomas Using (68)Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI. J Nucl Med, 58(10), 1580-1587. doi:10.2967/jnumed.117.191932
- 2017
Molecular Imaging and Precision Medicine: PET/Computed Tomography and TherapyResponse Assessment in Oncology.
Sheikhbahaei, S., Mena, E., Pattanayak, P., Taghipour, M., Solnes, L. B., & Subramaniam, R. M. (2017). Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology. PET Clin, 12(1), 105-118. doi:10.1016/j.cpet.2016.08.002
- 2017
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati, A., Duan, F., Snyder, B. S., Wei, B., Houshmand, S., Khiewvan, B., . . . Alavi, A. (2017). Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. Eur J Nucl Med Mol Imaging, 44(12), 1969-1983. doi:10.1007/s00259-017-3753-x
- 2017
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna, H., McConkey, C. C., Rahman, J. K., Wong, W. L., Smith, A. F., Nutting, C., . . . Dunn, J. A. (2017). PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Health Technol Assess, 21(17), 1-122. doi:10.3310/hta21170
- 2017
Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis.
Hallqvist, A., Alverbratt, C., Strandell, A., Samuelsson, O., Björkander, E., Liljegren, A., & Albertsson, P. (2017). Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis. Radiother Oncol, 123(1), 71-77. doi:10.1016/j.radonc.2017.02.011
- ‹ previous
- 7 of 11
- next ›